Bright Minds Biosciences Inc. (CSE:DRUG)
Canada · Delayed Price · Currency is CAD 26.00
-0.11 (-0.42%)
Nov 5, 2026, 4:44 PM EST
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of CAD 256.47 million as of November 6, 2026. It is the 20,978th most valuable company in the world and the 512th biggest in Canada. Its market cap has decreased by 54.76% in one year.
Market Cap
256.47M
Enterprise Value
-51.30M
Revenue
n/a
Global Rank
Country Rank
#512 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from 53.34M to 256.47M, an increase of 380.85%. That is a compound annual growth rate of 31.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 256.47M | -70.18% |
| Dec 31, 2025 | 859.94M | 138.45% |
| Dec 31, 2024 | 360.63M | 3,710.83% |
| Dec 29, 2023 | 9.46M | -50.41% |
| Dec 30, 2022 | 19.08M | -60.52% |
| Dec 31, 2021 | 48.34M | -9.37% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 637.32M |
| Satellos Bioscience | 216.41M |
| Eastwood Bio-Medical Canada | 123.99M |
| Helix BioPharma | 68.74M |
| BriaCell Therapeutics | 49.51M |
| NurExone Biologic | 45.79M |
| Thiogenesis Therapeutics | 44.79M |
| Sharp Therapeutics | 43.26M |